RCM
DXCM icon

Raleigh Capital Management’s DexCom DXCM Stock Holding History

Raleigh Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-204
Closed -$15.9K – 699
2024
Q4 		$15.9K Buy
204
+85
+71% +$6.29K 0.01% 509
2024
Q3 		$7.98K Sell
119
-33
-22% -$2.71K ﹤0.01% 634
2024
Q2 		$17.2K Buy
152
+1
+0.7% +$126 0.01% 450
2024
Q1 		$20.9K Buy
151
+97
+180% +$12.2K 0.01% 417
2023
Q4 		$6.71K Buy
54
+50
+1,250% +$5.11K ﹤0.01% 679
2023
Q3 		$384 Buy
+4
New +$451 ﹤0.01% 897
2023
Q2 		– Sell
-23
Closed -$2.67K – 861
2023
Q1 		$2.67K Buy
+23
New +$2.58K ﹤0.01% 736

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Raleigh Capital Management's DXCM Position: Q1 2025 in Review

Raleigh Capital Management sold out of DexCom (DXCM) in Q1 2025, closing a stake of 204 shares — an estimated $15.9K sold.

Raleigh Capital Management first reported a position in DXCM in Q1 2023 and held it in 7 quarters. The position peaked at $20.9K in Q1 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Raleigh Capital Management reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 204 DexCom shares in Q1 2025, an estimated $15.9K.
  • Raleigh Capital Management first reported a position in DexCom in Q1 2023 and held it in 7 quarters.
  • Raleigh Capital Management's DexCom position peaked at $20.9K in Q1 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.